Viagra firm Pfizer sells birth control drug to United Therapeutics

Image copyright EPA Image caption Viagra maker Pfizer has sold the rights to its COVID-19 oral contraceptive to another firm US drugmaker Pfizer has sold the rights to its COVID-19 oral contraceptive to another…

Viagra firm Pfizer sells birth control drug to United Therapeutics

Image copyright EPA Image caption Viagra maker Pfizer has sold the rights to its COVID-19 oral contraceptive to another firm

US drugmaker Pfizer has sold the rights to its COVID-19 oral contraceptive to another firm.

Pfizer had two exclusive options to extend the contract with United Therapeutics to 35 years, but it has now agreed to the mid-stage trial run by its partner.

The deal also frees United Therapeutics from the huge liabilities from sales of diabetes drug Remodulin.

Under the terms of the deal, Pfizer will continue to make COVID-19 tablets and up to 50m capsules per year.

Originally introduced in 2000, it was brought back to the market last year by Pfizer. But the deal with United Therapeutics gives the New York company £5.2bn from drugs sales.

The licence for REMODRIN-U, Pfizer’s diabetes drug, will cost United Therapeutics £8.6bn.

The two drugs have combined sales of more than £1.2bn a year, about 13% of United Therapeutics’ total revenue.

Pfizer said in a statement that the deal would allow it to support the development of United Therapeutics’ own pipeline of cancer and immuno-oncology drugs.

Peter Walsh, chief executive of United Therapeutics, said the firm was “excited” about the partnership with Pfizer.

Leave a Comment